| Mrs Cheryl Kay Nacos, PHARM D | |
|
1024 S Lemay Ave, Fort Collins, CO 80524-3929 | |
| (970) 495-8030 | |
| (970) 495-7615 |
| Full Name | Mrs Cheryl Kay Nacos |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Oncology |
| Location | 1024 S Lemay Ave, Fort Collins, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073984464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835X0200X | Pharmacist - Oncology | 17537 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cheryl Kay Nacos, PHARM D 1024 S Lemay Ave, Fort Collins, CO 80524-3929 Ph: (970) 495-8030 | Mrs Cheryl Kay Nacos, PHARM D 1024 S Lemay Ave, Fort Collins, CO 80524-3929 Ph: (970) 495-8030 |
News Archive
A computer scientist at Washington University in St. Louis has developed a novel technique to extract more DNA from a single sequence reaction than is normally possible, reducing both cost and time of the sequencing process.
The "First international consensus on the diagnosis and management of fibromuscular dysplasia" (FMD) has been published online first today in Vascular Medicine and the Journal of Hypertension.
The FBI is interviewing witnesses about billing practices at Prime Healthcare Services, the hospital chain that has charged Medicare for treating elderly patients with rare medical conditions at far higher rates than other California hospitals. The FBI would neither confirm nor deny an investigation, but at least two former Prime medical coders say they were approached by the agency to discuss the chain's billing practices. ... A spokesman for Prime said the chain is unaware of an FBI probe.
Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready, orally administered small molecule in clinical development for neuropathic pain.
Anchor Therapeutics today announced the publication of new research in the Proceedings of the National Academy of Sciences USA. The paper describes the identification and characterization of a pepducin-based allosteric agonist that targets CXCR4, a chemokine G protein-coupled receptor found on hematopoietic stem cells and other bone marrow-derived cells.
› Verified 8 days ago
Anuj Basnet, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2190 W Drake Rd, Fort Collins, CO 80526 Phone: 970-484-5841 | |
Jason Deboodt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2160 W Drake Rd, Fort Collins, CO 80526 Phone: 970-484-2843 Fax: 970-490-2774 | |
Dr. Hafiz Tayebali, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 W Troutman Pkwy, Fort Collins, CO 80525 Phone: 970-223-0840 | |
Debra Lyons, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 S Drive, Fort Collins, CO 80523 Phone: 970-491-1402 Fax: 970-491-4874 | |
Dr. Lindsay Nicole Curry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 460 S College Ave, Fort Collins, CO 80524 Phone: 970-484-9534 Fax: 970-484-8367 | |
Dr. Steven Schoeber, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1426 E Harmony Rd, Fort Collins, CO 80525 Phone: 970-223-2556 | |
Dr. Jennifer Petrie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2025 Bighorn Rd, Fort Collins, CO 80525 Phone: 970-449-0082 |